Compare EOLS & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EOLS | GCO |
|---|---|---|
| Founded | 2012 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 284.3M | 286.0M |
| IPO Year | 2018 | 1994 |
| Metric | EOLS | GCO |
|---|---|---|
| Price | $6.49 | $32.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $15.50 | ★ $33.00 |
| AVG Volume (30 Days) | ★ 948.3K | 157.0K |
| Earning Date | 05-04-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 1.23 | ★ 171.84 |
| EPS | N/A | ★ 1.25 |
| Revenue | $297,176,000.00 | ★ $2,606,898,000.00 |
| Revenue This Year | $13.27 | $0.78 |
| Revenue Next Year | $17.62 | $2.12 |
| P/E Ratio | ★ N/A | $25.74 |
| Revenue Growth | 11.61 | ★ 13.71 |
| 52 Week Low | $3.86 | $19.62 |
| 52 Week High | $10.62 | $38.95 |
| Indicator | EOLS | GCO |
|---|---|---|
| Relative Strength Index (RSI) | 69.96 | 47.81 |
| Support Level | $6.44 | $30.79 |
| Resistance Level | $7.29 | $33.29 |
| Average True Range (ATR) | 0.38 | 1.64 |
| MACD | 0.03 | -0.45 |
| Stochastic Oscillator | 83.62 | 30.42 |
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.
Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.